NTRK Targeted Therapy Test | Lahalak Platform
Innovative analysis to detect NTRK gene fusion, opening new horizons for effective targeted therapies for rare and resistant cancers, ensuring personalized and highly accurate medical care for patients.
Scientific name: Immunohistochemistry (IHC) for NTRK
Immunohistochemical (IHC) testing for NTRK (Neurotrophic Tyrosine Receptor Kinase 1/2/3) proteins aims to detect abnormal or excessive protein expression of TRKA, TRKB, or TRKC, which may indicate a gene fusion in the NTRK1, NTRK2, or NTRK3 genes. This test is a rapid and cost-effective initial screening tool for identifying patients who may have t...
Service type
Laboratory test (Tissue)
Duration
10-15 minutes
Fasting
Fasting is not required
Included Services
- Detailed analytical testing to detect NTRK protein expression in tumor tissue samples
- Consult with a pathologist or molecular oncologist to interpret the results.
- Personal support services from Lahalak
Medical Service Information
Conditions & Notices
- Fasting is not required, as the sample is tissue (biopsy or excision).
- The tissue sample must be immediately preserved in 10% formalin.
- This analysis is increasingly used in the comprehensive screening of rare, resistant, or advanced tumors, or in epidemiologically related tumors known to contain NTRK fusions.
- The request for this test must be accompanied by an explanation of the possibility of requesting molecular confirmatory tests (FISH/NGS) in case of a positive result.
Medical services you might also like
